COMPOSICION FARMACEUTICA SOLIDA ORAL QUE COMPRENDE UN PRINCIPIO ACTIVO Y POLIVINILPIRROLIDONA (PVP) ENTRE 1,0-25%, CPAA ENTRE 0,5-10%, EL PRINCIPIO ACTIVO CONSISTE EN UNA SAL HIDROSOLUBLE DE METAL ALCALINO, DE METAL ALCALINO-TERREO, UNA SAL DE MEZCLA

COMPOSICION FARMACEUTICA SOLIDA ORAL QUE COMPRENDE UN PRINCIPIO ACTIVO Y POLIVINILPIRROLIDONA (PVP) ENTRE 1,0-25%, CPAA ENTRE 0,5-10%, EL PRINCIPIO ACTIVO CONSISTE EN UNA SAL HIDROSOLUBLE DE METAL ALCALINO, DE METAL ALCALINO-TERREO, UNA SAL DE MEZCLA

The present invention is directed to a novel short term slow release drug delivery system, preferably for solid oral dosage forms of water-soluble, alkaline salts of alkali metals and alkaline earth metals comprising polyvinylpyrrolidone and CPAA and preferably a wax component.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WALSDORF, NEILL B., TAYLOR, JON C., ZHANG, FENG, SHERWOOD, FRANCIS K., KOLENG, JOHN J
Format: Patent
Sprache:spa
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention is directed to a novel short term slow release drug delivery system, preferably for solid oral dosage forms of water-soluble, alkaline salts of alkali metals and alkaline earth metals comprising polyvinylpyrrolidone and CPAA and preferably a wax component.